Found 22 clinical trials
Adenoid Cystic Carcinoma Erbitux and Particle Therapy
The ACCEPT (A(denoid) c(ystic) c(arcinoma), E(rbitux, and) p(article) t(herapy))-trial is a prospective, monocentric phase I/II feasibility trial evaluating toxicity and efficacy in the combined treatment of intensity-modulated radiation therapy (IMRT) and carbon ion (C12) boost with the epidermal growth factor receptor (EGFR) antibody cetuximab. The primary objective of the study …
- 68 views
- 08 Nov, 2020
Tyrosine Kinase Inhibitors in Metastastic Adenoid Cystic Carcinoma
no clinical study on epidermal growth factor receptor tyrosine kinase inhibitors has been systematically conducted in adenoid cystic carcinoma. We design this phase II study EGFR TKIs in
- 3 views
- 31 Jul, 2021
- 1 location
All-trans Retinoic Acid (ATRA) in the Treatment of Recurrent/Metastatic Adenoid Cystic Carcinoma of the Head and Neck
metastatic adenoid cystic carcinoma of the head and neck.
- 0 views
- 25 Jan, 2021
- 1 location
Study of Intratumoral CV8102 in cMEL cSCC hnSCC and ACC
cystic carcinoma. Patients will receive CV8102 as single agent or in combination with SoC anti-PD-1 therapy.
- 136 views
- 13 Aug, 2021
- 60 locations
Study of CB-103 in Adult Patients With Advanced or Metastatic Solid Tumours and Haematological Malignancies
This is a phase I/II, non randomized, open-label, dose escalation study to investigate the safety, tolerability and preliminary efficacy of CB-103.
- 281 views
- 26 Jan, 2021
- 12 locations
Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
) Rare Tumors [To obtain permission to enroll in the NOC cohort, contact: S1609SC@swog.org] (closed to accrual 03/15/2019) Adenoid cystic carcinoma (closed
- 6048 views
- 16 Sep, 2021
- 818 locations
Adenoid Cystic Carcinoma and Carbon Ion Only Irradiation
. The present ACCO (Adenoid Cystic Carcinoma and Carbon ion Only irradiation) study, a prospective, open-label, phase II, single-arm, investigator-initiated study, will therefore investigate the sole
- 0 views
- 05 Sep, 2021
- 1 location
Study of Imatinib (Glivec) in Patients With Adenoid Cystic Carcinoma of the Head and Neck
This is a Phase II study of imatinib (Glivec) administered as a daily oral treatment in patients with recurrent/metastatic adenoid cystic carcinoma of the head and neck overexpressing KIT.
- 53 views
- 07 Nov, 2020
- 1 location
Axitinib and Avelumab in Treating Patients With Recurrent or Metastatic Adenoid Cystic Carcinoma
This phase II trial studies how well axitinib and avelumab work in treating patients with adenoid cystic carcinoma that has come back or spread to other places in the body. Axitinib may stop the
- 2 views
- 23 Jan, 2021
- 1 location
Lenvatinib and Pembrolizumab in People With Advanced Adenoid Cystic Carcinoma and Other Salivary Gland Cancers
The purpose of this study is to see if the study drugs, lenvatinib and pembrolizumab, are effective in treating advanced Adenoid Cystic Carcinoma (ACC) or other salivary gland cancers that have
- 0 views
- 21 May, 2021
- 8 locations